Waters Corporation and BioCity announced an agreement to launch an open access analytical laboratory. Located in the BioHub at Alderley Park, the laboratory will offer Waters' liquid chromatography (LC), mass spectrometry (MS) and informatics technologies, along with a suite of analytical platforms to scientists working in the pharmaceutical and life science industries. The laboratory will be resourced with many of Waters' latest technology offerings, including ACQUITY® QDa®ACQUITY H-Class™, ACQUITY UPC2®and ACQUITY PDA Detector™, along with the expertise required to leverage the power of these instrumentation platforms. The laboratory will also include a nuclear magnetic resonance (NMR) system provided by Manchester Science Partnerships, the owners of Alderley Park.

Scheduled to open in early 2016, the Waters/BioCity laboratory will add to Alderley Park's scientific heritage and complement its cutting edge research facilities.